Perrigo to switch to NYSE from Nasdaq

The pharmaceutical company will transfer its listing to the New York Stock Exchange on June 6.

Perrigo Company (Nasdaq:PRGO; TASE:PRGO) today announced that it will transfer its listing from Nasdaq to the New York Stock Exchange on June 6. It will keep its ticker "PRGO". To mark the occasion, company representatives will ring the opening bell.

Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) transferred from Nasdaq to the NYSE.

Perrigo chairman and CEO Joseph Papa said, "We are looking forward to listing on the NYSE as this change will provide increased visibility and enhanced services that will benefit our shareholders. We remain committed to making quality healthcare more affordable for our customers and patients and continuing to increase shareholder value."

"Perrigo and the NYSE are a perfect fit, and we're thrilled to welcome one of the world's leading healthcare suppliers to the world's leading equities market," said NYSE Euronext CEO Duncan Niederauer. "Perrigo was founded more than a century ago seeking to best serve and empower customers, continually innovate, and deliver quality products. That vision, which remains in place today, set the stage for the company's growth and global leadership."

Published by Globes [online], Israel business news - - on May 23, 2013

© Copyright of Globes Publisher Itonut (1983) Ltd. 2013

View comments in rows
Update by email about comments talkback
Your name
Please insert your name
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Twitter Facebook Linkedin RSS Newsletters גלובס Capital  Markets Conference 2017